---
figid: PMC6129988__nihms-1501617-f0001
figlink: /pmc/articles/PMC6129988/figure/F1/
number: F1
caption: Psoriasis initiation begins with environmental triggers and/or loss of tolerance,
  which leads to activation of plasmacytoid dendritic cells (pDCs) and IL-23-producing
  dermal DCs. Several pro-inflammatory DC cell populations present psoriasis autoantigens
  and trigger T17 cell polarization and clonal expansion. Activated T17 cells produce
  key cytokines including IL-17, IL-26, IL-29, and TNFα that act on epidermal keratinocytes
  to promote a feed-forward inflammatory response in skin. IL-17 acting alone or synergistically
  with TNFα induces expression of psoriasis-related genes in keratinocytes leading
  to epidermal hyperplasia and the production of antimicrobial peptides (e.g. hBD2,
  S100s, and LL37/cathelicidin). Keratinocyte-derived CCR20 recruits CCR6+ cells (IL-23-producing
  TIP-DCs and IL-17-producing T cells) to further promote inflammation. CXCL1/2/3/5/8
  are also produced by keratinocytes and recruit neutrophils and macrophages into
  inflamed skin. IL-23 promotes the clonal expansion and differentiation of T22 cells
  that produce IL-22, which works together with IL-19/IL-36γ to alter the terminal
  differentiation and proliferation of keratinocytes. IL-12 produced by activated
  DCs as well as keratinocyte-derived CXCL9/10/11 promotes the influx of Th1 cells
  into lesional psoriatic skin. Type 3 innate lymphoid cells (ILC3) in the skin also
  produce IL-17 and IL-22, which contribute to the development of skin inflammation.
pmcid: PMC6129988
papertitle: Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.
reftext: Jason E. Hawkes, et al. J Immunol. 2018 Sep 15;201(6):1605-1613.
pmc_ranked_result_index: '162799'
pathway_score: 0.7593332
filename: nihms-1501617-f0001.jpg
figtitle: Current pathogenic model of psoriasis
year: '2018'
organisms:
- Homo sapiens
ndex: 510e7bbf-df2c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6129988__nihms-1501617-f0001.html
  '@type': Dataset
  description: Psoriasis initiation begins with environmental triggers and/or loss
    of tolerance, which leads to activation of plasmacytoid dendritic cells (pDCs)
    and IL-23-producing dermal DCs. Several pro-inflammatory DC cell populations present
    psoriasis autoantigens and trigger T17 cell polarization and clonal expansion.
    Activated T17 cells produce key cytokines including IL-17, IL-26, IL-29, and TNFα
    that act on epidermal keratinocytes to promote a feed-forward inflammatory response
    in skin. IL-17 acting alone or synergistically with TNFα induces expression of
    psoriasis-related genes in keratinocytes leading to epidermal hyperplasia and
    the production of antimicrobial peptides (e.g. hBD2, S100s, and LL37/cathelicidin).
    Keratinocyte-derived CCR20 recruits CCR6+ cells (IL-23-producing TIP-DCs and IL-17-producing
    T cells) to further promote inflammation. CXCL1/2/3/5/8 are also produced by keratinocytes
    and recruit neutrophils and macrophages into inflamed skin. IL-23 promotes the
    clonal expansion and differentiation of T22 cells that produce IL-22, which works
    together with IL-19/IL-36γ to alter the terminal differentiation and proliferation
    of keratinocytes. IL-12 produced by activated DCs as well as keratinocyte-derived
    CXCL9/10/11 promotes the influx of Th1 cells into lesional psoriatic skin. Type
    3 innate lymphoid cells (ILC3) in the skin also produce IL-17 and IL-22, which
    contribute to the development of skin inflammation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - STAT1
  - TNF
  - ITGAX
  - CCL20
  - NELFCD
  - CXCL2
  - LAMP3
  - CAMP
  - CXCL10
  - CXCL9
  - CCR6
  - IL17F
  - PDC
  - IL12A
  - CXCL3
  - CXCL5
  - CXCL11
  - CXCL8
  - LCN2
  - DEFB4A
  - IFNA1
  - CEBPB
  - IL12B
  - IL17C
  - CD83
  - IFNL1
  - IL22
  - CXCL1
  - IL26
  - IL17A
  - IL23A
  - IL19
  - AMPS
  - BDCA
  - psoriasis
genes:
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: (CD11c*)
  symbol: CD11c
  source: hgnc_alias_symbol
  hgnc_symbol: ITGAX
  entrez: '3687'
- word: CCL20
  symbol: CCL20
  source: hgnc_symbol
  hgnc_symbol: CCL20
  entrez: '6364'
- word: Th1
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: CXCL1/2/3/5/8
  symbol: CXCL2
  source: hgnc_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: '"DC-LAMP"")"'
  symbol: DC-LAMP
  source: hgnc_alias_symbol
  hgnc_symbol: LAMP3
  entrez: '27074'
- word: (LL37,HBD2,S100s.LCN2)
  symbol: LL37
  source: hgnc_alias_symbol
  hgnc_symbol: CAMP
  entrez: '820'
- word: CXCL9/10/11
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: CXCL9/10/11
  symbol: CXCL9
  source: hgnc_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: CCR6*
  symbol: CCR6
  source: hgnc_symbol
  hgnc_symbol: CCR6
  entrez: '1235'
- word: IL-17A/F
  symbol: IL-17F
  source: hgnc_alias_symbol
  hgnc_symbol: IL17F
  entrez: '112744'
- word: pDC
  symbol: PDC
  source: hgnc_symbol
  hgnc_symbol: PDC
  entrez: '5132'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: CXCL1/2/3/5/8
  symbol: CXCL3
  source: hgnc_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: CXCL1/2/3/5/8
  symbol: CXCL5
  source: hgnc_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: CXCL9/10/11
  symbol: CXCL11
  source: hgnc_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: (IL-8)
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: LCN2)
  symbol: LCN2
  source: hgnc_symbol
  hgnc_symbol: LCN2
  entrez: '3934'
- word: (LL37,HBD2,S100s.LCN2)
  symbol: HBD-2
  source: hgnc_alias_symbol
  hgnc_symbol: DEFB4A
  entrez: '1673'
- word: CXCL1/2/3/5/8
  symbol: CXCL8
  source: hgnc_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IFN-
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: C/EBPB,8
  symbol: CEBPB
  source: hgnc_symbol
  hgnc_symbol: CEBPB
  entrez: '1051'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL-17C
  symbol: IL-17C
  source: hgnc_alias_symbol
  hgnc_symbol: IL17C
  entrez: '27189'
- word: (CD83*
  symbol: CD83
  source: hgnc_symbol
  hgnc_symbol: CD83
  entrez: '9308'
- word: IL-29
  symbol: IL-29
  source: hgnc_alias_symbol
  hgnc_symbol: IFNL1
  entrez: '282618'
- word: IL-22
  symbol: IL22
  source: hgnc_symbol
  hgnc_symbol: IL22
  entrez: '50616'
- word: CXCL1/2/3/5/8
  symbol: CXCL1
  source: hgnc_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: IL-26
  symbol: IL-26
  source: hgnc_alias_symbol
  hgnc_symbol: IL26
  entrez: '55801'
- word: IL-17A/F
  symbol: IL-17A
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: IL-23
  symbol: IL-23
  source: hgnc_alias_symbol
  hgnc_symbol: IL23A
  entrez: '51561'
- word: IL-19
  symbol: IL-19
  source: hgnc_alias_symbol
  hgnc_symbol: IL19
  entrez: '29949'
chemicals:
- word: AMPS
  source: MESH
  identifier: C056288
- word: BDCA
  source: MESH
  identifier: C478196
diseases:
- word: psoriasis
  source: MESH
  identifier: D011565
figid_alias: PMC6129988__F1
redirect_from: /figures/PMC6129988__F1
figtype: Figure
---
